Today, the first population-based, real-world evidence (RWE) of the positive benefits infants receive when passively immunized to prevent respiratory syncytial virus (RSV) disease was published.
RWE demonstrates if immunization is effective in day-to-day practice, as opposed to "efficacy" determined in carefully controlled clinical trials.
Read More
